Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | Healthcare | 662,470.0 | $38.5M | 8.82% | -75K | -10.2% | $58.11 | -16.6% |
| 2 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 1,738,110.0 | $32.9M | 7.53% | NEW | — | $18.90 | +8.4% |
| 3 | LBRX | LB PHARMACEUTICALS INC | Healthcare | 1,319,362.0 | $32.5M | 7.45% | -76K | -5.5% | $24.66 | +12.5% |
| 4 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 333,312.0 | $30.8M | 7.05% | +301K | +946.1% | $92.38 | +3.4% |
| 5 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 1,743,220.0 | $27.0M | 6.19% | — | — | $15.50 | +0.1% |
| 6 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 440,000.0 | $25.6M | 5.86% | -157K | -26.3% | $58.15 | -7.6% |
| 7 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 245,000.0 | $23.8M | 5.46% | NEW | — | $97.25 | +48.5% |
| 8 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 1,047,935.0 | $22.6M | 5.18% | +132K | +14.4% | $21.60 | +8.3% |
| 9 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 682,597.0 | $20.6M | 4.71% | — | — | $30.15 | -5.9% |
| 10 | CYTK | CYTOKINETICS INC | Healthcare | 300,000.0 | $19.8M | 4.53% | NEW | — | $65.91 | +14.1% |
| 11 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 701,821.0 | $16.4M | 3.76% | NEW | — | $23.36 | -16.9% |
| 12 | NGNE | NEUROGENE INC | Healthcare | 782,787.0 | $15.8M | 3.62% | — | — | $20.16 | +38.8% |
| 13 | IVA | INVENTIVA SA | Healthcare | 2,657,997.0 | $14.8M | 3.38% | — | — | $5.55 | -9.5% |
| 14 | — | INHIBIKASE THERAPEUTICS INC | — | 8,057,345.0 | $13.5M | 3.10% | +1.9M | +30.4% | $1.68 | — |
| 15 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 1,302,917.0 | $12.1M | 2.78% | NEW | — | $9.31 | -10.1% |
| 16 | XENE PUT | XENON PHARMACEUTICALS INC | Healthcare | 200,000.0 | $11.6M | 2.66% | NEW | — | $58.15 | -7.6% |
| 17 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 2,571,478.0 | $10.6M | 2.43% | — | — | $4.13 | -11.9% |
| 18 | IMVT | IMMUNOVANT INC | Healthcare | 414,054.0 | $10.3M | 2.36% | +174K | +72.4% | $24.84 | +6.8% |
| 19 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 852,013.0 | $9.1M | 2.08% | NEW | — | $10.64 | +0.6% |
| 20 | CAMP | CAMP4 THERAPEUTICS CORP | Healthcare | 1,939,563.0 | $8.6M | 1.96% | -44K | -2.2% | $4.41 | -5.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%